讯飞医疗:累计亏损近6亿上市后仍未分红,董监高最高薪酬近1300万,高管薪金还在涨

秋山论商业
Feb 11

文 | 秋山论商业有着“医疗大模型第一股”之称的讯飞医疗,在2025年年末公布了一个利好消息,包括控股股东科大讯飞在内的八名主要股东,自愿将其所持公司股份的禁售期从原定的2025年12月29日延长至2026年12月29日。这波利好消息的释放,资本市场给出了积极回应,讯飞医疗的股价从2025年12月29日收盘时的72.05港元一路上涨,并在今年1月9日突破100港元,最高时达到了114.7港元,在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10